Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZNN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,433
Award facts
- Contract value 100% obligated
- $13,433.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,433.10 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's delivery orders through the DLA Medical Supply Chain vehicle typically involve firm fixed-price arrangements for diverse therapeutic products, ranging from diabetes and neurological medications to antibiotics and specialized medical supplies. This award of Xifaxan, an antibiotic treatment, reflects the company's ongoing role in fulfilling essential pharmaceutical needs across multiple federal healthcare institutions and demonstrates its capability to meet government procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F4ZNN?
SPE2DR26F4ZNN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4ZNN worth?
The government has obligated $13,433 on SPE2DR26F4ZNN.
Is contract SPE2DR26F4ZNN an order under another contract?
Yes. SPE2DR26F4ZNN is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZNN competed?
The extent of competition for SPE2DR26F4ZNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award